semaglutide update What the FDA's on means for you Wegovy (semaglutide 2.4 mg) approved

Unlike conventional ED medications that act on vascular pathways, PT-141 works centrally through the nervous system to enhance arousal and desire in both men and women

This means they can reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and type 2 diabetes mellitus (Ozempic) or obesity or overweight (Wegovy)

The modest amount of weight Desmond has lost on Wegovy so far probably doesnt explain his recent boost in libido

The Takeaway Microdosing GLP-1s is when you take a dose below the recommended dose for weight loss

Dosing principles remain similar (5002500 mcg range), but the choline and inositol components support mitochondrial energy and metabolism, which some providers use to guide slightly different frequency protocols

According to the STEP 1 trial published in the New England Journal of Medicine, patients taking semaglutide 2.4 mg (Wegovy) achieved approximately: 3% to 5% body weight loss by week 12 10% to 12% body weight loss by week 28 15% to 17% body weight loss by week 68 (maximum effect) These figures represent average outcomes in clinical trials